Previous 10 | Next 10 |
NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that the United States Pate...
NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, announced today that its nutraceutical divi...
SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that it has signed ...
SAN DIEGO , Sept. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, an...
NEW YORK , Sept. 10, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, announced today that its contract...
Delta, Kelowna, BC - August 8, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to ...
NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the United Sta...
NEW YORK, July 30, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has launched its ...
NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that the Company has receiv...
NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that the Company has signed...
News, Short Squeeze, Breakout and More Instantly...
Axim Biotechnologies Inc Company Name:
AXIM Stock Symbol:
OTCMKTS Market:
Axim Biotechnologies Inc Website:
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM's Diagnostic Research Programs in Dry Eye Disease and Parkinson's SAN DI...
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA - ( NewMediaWire ) - March 27, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,...
The Company’s Commercialization Partner Verséa Ophthalmic Places Re-stock Order of AXIM’s Digital Assay Reader SAN DIEGO, CA - ( NewMediaWire ) - February 20, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,” ...